Categories: News

NYSE Content Advisory: Pre-Market update + AstraZeneca Shares Begin Trading on NYSE in Record Transfer

NEW YORK, Feb. 2, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Kristen Scholer delivers the pre-market update on February 2nd

- Advertisement -
  • The major indices are slightly lower to start the week as volatility in precious metals sparks risk‑off sentiment, though the S&P 500 remains about one percent from its recent all‑time high above 7,000.
  • Today, AstraZeneca begins trading its ordinary shares on the New York Stock Exchange, marking the largest company transfer by market capitalization in the history of the NYSE.
  • With an ambition to grow revenue to $80 billion by 2030; 50% of which is to be generated in the U.S., AstraZeneca is investing in transformative technologies with the potential to reshape healthcare.
  • This afternoon, the NYSE hosts its second annual Partnership Day, and winter weather across the U.S. remains significant, with the final 10 days of January marking the coldest stretch since 1990 according to ICE.

Opening Bell
Compass International Holdings celebrates the launch of its newly combined organization

- Advertisement -

Closing Bell
The NYSE marks its 2nd Annual NYSE Partnership Day

- Advertisement -

Click here to download the NYSE TV App

- Advertisement -

Video – https://mma.prnewswire.com/media/2874735/NYSE_Market_Update_Feb_2.mp4

- Advertisement -

Logo – https://mma.prnewswire.com/media/2581322/New_York_Stock_Exchange_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–astrazeneca-shares-begin-trading-on-nyse-in-record-transfer-302676353.html

- Advertisement -

Recent Posts

Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development

Includes novel proteomic and genomic approaches to oncology therapeutic selection, response monitoring, and Molecular Residual…

10 hours ago

Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares

April 06, 2026 10:53 ET  | Source: Celldex Therapeutics, Inc. HAMPTON, N.J., April 06, 2026…

10 hours ago

Sienna Senior Living recognized by The Globe and Mails Women Lead Here Benchmark

April 06, 2026 10:25 ET  | Source: Sienna Senior Living MARKHAM, Ontario, April 06, 2026…

10 hours ago

Varhad Capital signs MoU with Velocys to develop Make-In-India, costcompetitive biomass-to-SAF projects

HOUSTON and NAGPUR, India, April 6, 2026 /PRNewswire/ -- Sustainable fuel technology provider Velocys and Varhad…

12 hours ago

NYSE Content Update: Join Us and 6,500+ Attendees at Marquee AI Event HumanX

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, April 6, 2026…

12 hours ago

Crypto Rails, Fiat Familiarity: Bybit Launches “Send Money” Feature to Simplify Global Transfers

DUBAI, UAE, April 6, 2026 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading…

12 hours ago